July 08, 2015
Trimb and Avista Capital Partners form strategic partnership
Media
July 02, 2015
Closing of the acquisition of Oncos Therapeutics Oy
July 02, 2015
Wilson Therapeutics Appoints Hans Schikan to its Board of Directors
July 02, 2015
Cortendo Provides 2015 Half-Year Update on Corporate Progress
July 01, 2015
Lancet Publication of Sham-Controlled Clinical Trial Shows Pulmonx’s Zephyr Endobronchial Valves Deliver Significant Benefit to Emphysema Patients
June 25, 2015
Orexo’s “Out the Monster” campaign wins a Gold Lions Health Award at the Cannes Lions Festival
June 17, 2015
WILSON THERAPEUTICS ANNOUNCES SUPPORT OF THE BIG WOW TO RAISE AWARENESS OF WILSON’S DISEASE
June 17, 2015
UPDATED RESULTS OF ONGOING PHASE 1/2 STUDY WITH BETALUTIN™ IN RELAPSED CD37+ NON-HODGKIN LYMPHOMA PATIENTS
June 12, 2015
Heavily Pretreated, Relapsed and Relapsed Refractory Multiple Myeloma Patients Showed Significant Clinical Benefit, as Measured by Overall Response Rate and Progression Free Survival, when Treated with Melflufen and Dexamethasone
June 11, 2015
Creating Nordic leader in immuno oncology